LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹46.58 | ₹36.40 | ₹34.63 | ₹31.08 | ₹25.72 |
What is the latest Earnings Per Share (EPS) of LINCOLN PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹46.58 |
| Mar2024 | ₹36.40 |
| Mar2023 | ₹34.63 |
| Mar2022 | ₹31.08 |
| Mar2021 | ₹25.72 |
How is Earnings Per Share (EPS) of LINCOLN PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹46.58 | 27.97 | |
| Mar2024 | ₹36.40 | 5.11 | |
| Mar2023 | ₹34.63 | 11.42 | |
| Mar2022 | ₹31.08 | 20.84 | |
| Mar2021 | ₹25.72 | - | |
Compare Earnings Per Share (EPS) of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹920.4 Cr | -1.2% | -5.5% | -35.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -1.2% |
-5.5% |
-35.7% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses